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Increasing evidence indicates that tumors require a constant influx
of myelomonocytic cells to support their malignant behavior. This
is caused by tumor-derived factors, which recruit and induce
functional differentiation of myelomonocytic cells, most of which
are macrophages. Although myeloid lineages are the classical
precursors of macrophages, B-lymphoid lineages such as B-1 cells,
a subset of B-lymphocytes found predominantly in pleural and
peritoneal cavities, are also able to migrate to inflammatory
sites and differentiate into mononuclear phagocytes exhibiting
macrophage-like phenotypes. Here we examined the interplay of
B-1 cells and tumor cells, and checked whether this interaction
provides signals to influence melanoma cells metastases. Using
in vitro coculture experiments we showed that B16, a murine
melanoma cell line, and B-1 cells physically interact. Moreover,
interaction of B16 with B-1 cells leads to up-regulation of
metastasis-related gene expression (MMP-9 and CXCR-4), increasing
its metastatic potential, as revealed by experimental metastases
assays in vivo. We also provide evidence that B16 cells exhibit
markedly up-regulated phosphorylation of the extracellular signal–
regulated kinase (ERK) when cocultured with B-1 cells. Inhibition of
ERK phosphorylation induced by B-1 cells with inhibitors of MEK1/
2 strongly suppressed the induction of MMP-9 and CXCR-4 mRNA
expression and impaired the increased metastatic behavior of B16.
In addition, constitutive levels of ERK1/2 phosphorylation in B-1
cells are necessary for their commitment to affect the metastatic
potential of B16 cells. Our findings show for the first time that B-1
lymphocytes can contribute to tumor cell properties required for
invasiveness during metastatic spread. (Cancer Sci 2008; 99: 920–928)
It is known from a variety of experimental systems that duringtumor progression and metastasis, an active crosstalk occurs
between tumor cells and their stroma, mainly mediated by direct
cell–cell contact, or paracrine cytokine and growth factor
signaling.(1–3) This tumor–stroma interplay suggests that tumors
are not autonomous masses of cells but function as a complex
system of many cell types.(4) However, the precise nature of the
cells that comprise normal stroma, how these cells or newly
recruited cells are altered during tumor progression, and how
they reciprocally interact are still poorly understood.
Most solid tumor masses, regardless of their histological
type, contain a significant proportion of inflammatory cells.
Among these cells, the tumor-associated macrophages (TAMs),
constitute the major inflammatory component of the stroma of
many tumors.(5) The role of TAMs in tumor progression and
metastasis is extensive, affecting different aspects of the neo-
plastic tissue, since they produce a myriad of cytokines, chem-
okines, growth factors, metalloproteinases, and other bioactive
mediators that may facilitate tumor-cell proliferation, survival,
and invasion.(6,7)
Myelomonocytic lineage represents precursor cells that serve
as a source for the constant renewal of tissue macrophages on
demand as well as in steady-state conditions. It is thought that
monocytes in the peripheral circulation are recruited to the
tumor site by the release of chemotactic cytokines where they
differentiate to become TAMs.(8,9)
More recently, immature myeloid cells (ImCs), which express
the Gr-1 (Ly6G) and Mac-1 (CD11b) markers have also been
demonstrated to accumulate in tumor sites.(10,11) ImCs derived
from tumor-bearing mice are able to differentiate in vitro toward
macrophages,(10,12–14) suggesting that undifferentiated myeloid
cells represent another source of TAMs in the neoplastic tissue.
Although it is well established that myeloid lineages are the
classical precursors of macrophages, several lines of evidences
suggest that in addition to myeloid lineages, B-lymphoid line-
ages can also generate phagocytic descendents exhibiting
macrophage-like characteristics. This is based on studies show-
ing that B-1 cells, an exclusive subset of B-lymphocytes that are
found predominantly in pleural and peritoneal cavities,(15,16) are
able to differentiate in vitro into mononuclear phagocytes exhib-
iting macrophage-like phenotypes.(17) Moreover, B-1 cells in
vivo can exit the peritoneal cavity and migrate to sites of inflam-
mation where they differentiate into macrophage-like cells.(17) In
another study, a subset of normal mouse splenic B-lymphocytes,
B-1a subset, became B/macrophage (B/M) cells after coculture
with normal fibroblasts, which simultaneously expressed the B-
cell markers B220, functional surface IgM, and surface IgD,
along with the macrophage markers F4/80 and Mac-1.(18)
Together these findings suggest that both B-lymphoid and mye-
loid lineages are not distantly related but share signatures in
their potential as precursors of mononuclear phagocytic cells.
However, in spite of the conceivable role of myeloid precur-
sor cells themselves, and their descendents such as TAMs, as
modulators of the tumor microenvironment, the interaction
between tumor cells and B-lymphoid lineages such as B-1 cells
and the influence that these cells may exert on tumor progres-
sion and metastasis have never been addressed.
In the present study we explored the interplay of B-1 cells
and melanoma cells, aiming to uncover if this interaction pro-
vides signals to modulate melanoma-cell metastases. We estab-
lished an in vitro heterotypic coculture system and determined
the nature of the intercellular communication between B-1
and melanoma cells. We also evaluated how this interaction
affects melanoma-cell metastases in vivo and examined particu-
lar aspects of molecular pathways known to be involved in the
metastatic process.
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Materials and Methods
Mice. Female C57BL/6 wild-type mice, 6–8-weeks-old, were
obtained from the animal facilities at the National Institute of
Pharmacology (INFAR), Federal University of São Paulo
(UNIFESP). Female C57BL/6 interleukin-10 (IL-10) knock-out
mice, 6–8-weeks-old, were a gift from Dr João Santana da Silva
(Department of Pharmacology, School of Medicine, University
of São Paulo (USP), Riberão Preto). All mice were housed in a
specific pathogen-free facility and were given autoclaved food
and water. The procedures that were followed in animal studies were
reviewed and approved by our Institutional Animal Committee.
Cell culture. B16 melanoma cells: B16 mouse melanoma
cells with low metastatic potential were used in this study.(19)
Cells were maintained in RPMI-1640 medium (Sigma, St Louis,
MO, USA) supplemented with 10% of fetal calf serum (FCS)
(Cultilab, Campinas, SP, Brazil) and 0.01% of antibiotics
(complete medium). Cultures were kept at 37°C in a humidified
atmosphere of 5% CO2-incubator as monolayer cultures. B-1
cells: B-1 lymphocytes were obtained as previously
described by Almeida et al.(17) Briefly, peritoneal cavity
washout of C57BL/6 wild-type or C57BL/6 IL-10 knock-out
mice was seeded onto a tissue culture dish for 2 h at 37°C.
Adherent cells were detached by scraping, and they were
washed and resuspended in RPMI-1640 medium containing
10% heat-inactivated FCS and 0.01% of antibiotics, and
cultured for 7 days without changing the medium. B-1 cells
grew in these cultures as free-floating cells. B-1 cell cultures
obtained from peritoneal washes were assessed by flow
cytometry (FACS) analysis using anti-B220 and anti-MAC1
antibodies before each experiment.
Cocultures of B16 and B-1 cells. B16 cells (105) were plated
onto culture dishes in complete medium and cells were left to
adhere for 24 h. After this period, the medium was removed
from B16 cells culture, 10 mL of complete medium containing
nonadherent B-1 cells (106) was added, and both cells were
cocultured for different times. After those periods B-1 cells were
removed by aspiration and adherent B16 cells were washed
three times with phosphate-buffered saline (PBS) to remove
all the remaining B-1 cells. B16 cells were then trypsinized,
resuspended in 10 mL of complete medium, and B16/B-1 cells
free from cocultures were systematically analyzed for the
presence of B-1 cells markers B220 and Mac-1 by FACS, to
assure that B16 cells were indeed free from B-1 cells after
coculturing. B16 and B-1 monocultures or B16 cells/B-1-cell
free from cocultures were used either for total-cell-extract
preparation or submitted to experimental metastasis assay.
Alternatively, after adhesion of B16 cells to the plates, cells
were washed with PBS and cultures were serum-starved
overnight. After this period, B-1 cells (106) were added to B16
cell plates and both cells were kept in serum free conditions for
1 h. B-1 cells were then removed as described above and B16/
B-1 cells free from cocultures were used for total-cell-extract
preparation and Western blot analysis.
Analysis of cell surface molecules by FACS. Cells were collected
and washed twice with PBS and adjusted at a concentration of
106 cells/sample. Cells were double-stained with phycoerytrin-
labeled anti-B220 and fluorescein-isothiocyanate-labeled anti-
MAC-1 (Pharmingen, San Diego, CA, USA), diluted 1:100 in
1% bovine serum albumine (BSA) in PBS, and incubated for 1 h
in the dark, on ice. After this, cells were washed and resus-
pended in 500 μL PBS and doubled-marked cell populations
were analyzed by the CellQuest program using FACSCalibur
(Beckton Dickinson, Mountain View, CA, USA).
Inhibition of cellular attachment. To yield a nonadherent
culture condition, cells were plated onto culture dishes
precoated with agarose 1% and incubated at 37°C and 5% CO2
for 72 h. After this, cells in suspension were collected from
the agarose coated dishes by pipetting and cell viability was
evaluated by trypan blue dye exclusion test. Cell aggregates
were mechanically separated, counted, and prepared for experi-
mental metastasis assay.
Experimental metastasis assay. Cells were collected and
resuspended in PBS to a concentration of 106 cells per ml. Then,
105 cells (0.1 mL) were injected into the lateral tail vein of
syngeneic C57BL/6 mice using a 27-gauge needle. Each
experimental group contained at least three animals. Mice
were sacrificed 14 days postinoculation, lungs were surgically
removed, and metastatic tumor colonies in the lungs were
macroscopically scored.
Total cell lysate, Western blotting, antibodies, and inhibitors. For
total protein extraction, cells were washed twice with ice-cold
PBS pH 7.4, and then lyzed in 100 μL of lyzes buffer (20 mM
Tris-HCl pH 7.4, 100 mM NaCl, 1 mM Na3VO4, 50 mM NaF,
0.5% NP-40, 1 mM PMSF, 10 μg/mL each leupeptin and
aprotinin), for 10 min at 4°C, followed by centrifugation at
17 740g for 15 min at 4°C. The supernatant was collected and
protein concentration was measured by the Bradford method.
Cell lysates were prepared with 5 X Laemmli buffer and boiled
for 5 min at 95°C. Equivalent amounts of protein (40 μg) were
separated by sodium dodecyl sulfate – polyacrylamide gel
electrophoresis (SDS-PAGE) and immunoblotted following
standard protocol,(20) using the following antibodies: phospho-
ERK (E-4, sc-7383) and total ERK (K-23, sc-94), obtained from
Santa Cruz Biotechnology (Santa Cruz, CA, USA). For
experiments aiming to inhibit phosphorylation of ERK, the
MEK inhibitor (PD98059) from Cell Signaling Technology
(Beverly, MA, USA) was employed.
Electron microscopy. Cocultures of B16 and B-1 cells were
performed in cover glass inside a 12-well plate (Costar). After
48 h of coculture, samples were fixed in 50% glutaraldehyde,
4% formaldehyde, and 0.2 M sodium cacodylate, pH 7.2 for 2 h.
Samples were washed with 0.1 M cacodylate buffer for 1 h
each. After being postfixed with 2% osmium tetroxide in 0.1 M
cacodylate buffer, samples were washed three times and
dehydrated in a crescent concentration of ethanol and propylene
oxide. Samples were embedded in Araldite resin and kept under
a vacuum for 4 h and were then polymerized at 60°C for 40 h.
Araldite-embedded samples were cut with glass knives. Ninety
to 95 μm thick sections were placed onto 300 mesh copper or
nickel grids and stained with 2% aqueous uranyl acetate for
8 min. These preparations were subsequently stained with lead
citrate in distilled water for 4 min. Grids were examined and
cells were photographed with a JEOL JEM 1200 EX II electron
microscope (JEOL, Tokyo, Japan).
IL-10 detection by ELISA. IL-10 concentration was determined
in culture supernatants of B-1 cells obtained from wild-type or
IL-10 knock-out mice. B-1 cells were cultivated as described
above and supernatants were collected after 7 days of culturing
and were maintained at 70°C until use. For cytokine
determination, microplates (Nunc) were sensitized overnight at
room temperature with anti-IL-10 monoclonal antibodies (R&D
Systems, Minneapolis, MN, USA) following the manufacturerís
recommendations. Plates were washed four times with PBS
containing 0.05% Tween 20 (PBS-T), and non-specific binding
was prevented by incubating the plates for 2 h at room
temperature with 200 μL per well of 3% BSA in PBS. Plates
were washed four times with PBS-T and incubated for 2 h with
100 μL per well of each supernatant, or with the IL-10 standard
curve (R&D Systems) diluted serially in PBS containing 2%
BSA. Plates were then washed four times with PBS-T and
incubated for 2 h with 100 μL/well of anti-IL-10 antibodies
(R&D Systems) at room temperature. Plates were then washed
four times with PBS-T and incubated for 20 min with
streptavidin-HRP at room temperature. Reactions were stopped
with 4 N H2SO4 (50 μL/well). Absorbance was read at 450 nm
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in a microplate reader apparatus (Labsystem Multiskan MN;
UNH, Santa Fe, NM, USA). The sensitivity of the test was
20 pg/mL. Results are reported as mean ± SD.
Quantitative real-time reverse transcription–polymerase chain
reaction (RT-PCR). Total RNA was extracted from cell cultures
with Trizol (Invitrogen, Carlsbad, CA, USA) according to the
manufactureís instructions. Three micrograms of RNA were
reverse-transcribed to cDNA with Superscript III (Invitrogen)
and normalized by PCR for glyceraldehydes 3′-phosphate
dehydrogenase (GAPDH), according to the manufacturerís
recommendations. Real-time PCR was performed on an ABI
7000 Real Time PCR System (Applied Biosystems, Foster City,
CA, USA) using the SYBR Green PCR Master Mix (Applied
Biosystems). The primers were obtained from Invitrogen, and
the sequences optimized for real-time PCR were as follows:
CXCR4 sense 5′-TGGAACCGATCAGTGTGAGT-3′ and
antisense 5′-GTAGATGGTGGGCAGGAAGA-3′, MMP-9 sense
5′-CATTCGCGTGGATAAGGAGT-3′ and antisense 5′-GGTC
CACCTTGTTCACC TCA-3′, GAPDH sense 5′-AAATG
GTGAAGGTCGGTGTG-3′ and antisense 5′-TGAAGGGG
TCGTTGATGG-3′. Samples were run in triplicate in three
independent assays and relative quantification of mRNA levels
was performed using the comparative threshold cycle method,
with amplification of the target genes and GAPDH in separate
tubes.
Statistical analysis. All data represent at least three
independent experiments and are expressed as mean ± SD.
Statistical comparisons were made by anova and by the Tukey–
Kramer test. P-values of less than 0.05 were considered
statistically significant.
Results
Establishment and characterization of the coculture system. In
order to determine whether B-1 cells (B-1) may affect the
metastatic potential of melanoma cells, 106 nonadhesive B-1
was cocultured for 48 and 72 h with 106 B16 mouse melanoma
cells of low metastatic potential. After these periods, B-1 was
washed off from the cocultures and B16 cells were injected into
the lateral tail vein of mice to investigate metastasis formation
in vivo. FACS showed that the doubled-marked cell population
for B-1 markers B220 and Mac-1 were presented on B-1
cells cultivated alone but were absent either on B16 cells mono-
culture or on B16/B-1 cells free after coculture, indicating the
absence of B-1 (Fig. 1a). After 14 days of inoculation,
metastatic tumor colonies in the lungs of animals were
macroscopically scored. The results in Figure 1b show that
inoculation of B16 from cocultures significantly increased
the numbers of lung colonies in a coculture in a time-dependent
manner compared with the control groups inoculated either with
B16 or B-1 cultivated alone. Also cocultures of 72 h were
generated to investigate the influence of increasing the number
of B1 cells on a fixed population of B16 cells. As shown in
Figure 1c, the metastatic behavior of B16 cells was significantly
Fig. 1. B-1 increases the metastatic behavior
of B16 cells after coculturing. (a) B-1 and B16
cells cultured alone or B16/B-1 cells free from
cocultures of 72 h were double-stained for B-
1 markers B220 and MAC-1 and analyzed by
flow cytometry analysis as described in
Materials and Methods. Double-marked cells
populations are shown on the upper right
panel and the percentage of cells is
indicated. (b) B-1 and B16 cultured alone or
B16 cocultured with B-1 (B16 + B1) were
cultured for 48 and 72 h. After these periods,
cells cultivated alone or B16/B-1 cells
free from cocultures were collected and
submitted to experimental metastasis assay.
(c) B16 cultured alone or 1 × 106 B16 cells
cocultured with different concentrations of
B-1 cells, as indicated, were cultured for 72 h.
After this period, B16 cells cultivated alone
or B16/B-1 cells free from cocultures were
collected and submitted to experimental
metastasis assay. (d) B-1, B16, or B16
cocultured with B-1 (B16 + B1), were plated
under nonadherent conditions for 72 h.
After this period, cells from monocultures or
mixed cocultured cells were collected and
submitted to experimental metastasis assay,
as described in Materials and Methods. Data
bars represent the mean number of tumor
colonies per lung per experimental condition
± SE. P < 0.05 represents statistical significance.
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increased when up to 105 B-1 cells, but not bellow this thres-
hold, were present in the coculture.
In our coculture system, B16 is a plastic adherent cell while
B-1 is nonadherent. Therefore, we checked if the increased met-
astatic behavior of B16, induced by the presence of B-1, is
dependent on the adhesion of B16 to the plastic. To test this,
both cell types were cocultured onto a nonadhesive substrate for
72 h and subjected to experimental metastasis assay in vivo. As
shown in Figure 1d, animals injected with B16/B-1 cells cocul-
tured in suspension also produced significantly larger numbers
of lung colonies compared to control groups injected either with
B16 or B-1 cultured alone on the same conditions. Loss of cell
viability was not observed in monocultures of both cell types
when held in suspension for 72 h (data not shown). Together
these findings indicate that the presence of B-1 altered the met-
astatic potential of B16 to behave more aggressively and that
adhesion of B16 is not necessary for this effect.
To test whether direct physical contact between B16 and B-1
is required, conditioned media from B-1 were added to B16-cell
culture. As shown in Figure 2a, no significant differences in the
numbers of lung metastasis were observed when B16 cells were
cultured in their own media compared to B16 cells cultured in
conditioned media either from B-1-cell single cultures or from
cocultures of B16/B-1 cells. On the other hand, the numbers of
lung metastasis were significantly increased when B16/B-1 cells
free from cocultures were injected. These results indicate that
B-1 soluble factors alone are not sufficient to support the
increased metastatic behavior of B16, suggesting that intercellu-
lar contact between them may occur. This idea is supported by
experiments where B16 and B-1 cells were cocultured for
48 h followed by electron transmission microscopy analysis.
Figure 2b shows a small B-1 cell with its atypical nuclear mor-
phology with re-entrances delimiting two distinct lobes.(21)
Membrane projections on B-1 are also seen contacting some
regions of the B16 cell membrane, which in some areas is pro-
truding in the form of an arm surrounding B-1. These observa-
tions indicate that there is indeed physical contact between these
cells during the coculture.
ERK phosphorylation is increased in B16 cells after interaction with 
B-1 cells. Considering that B16 and B-1 can physically interact,
we explored if signaling intermediates involved in metastasis
could be activated in B16 cells upon interaction with B-1.
Therefore we checked ERK, a downstream kinase of the MAPK
pathway. Activation of ERK requires its phosphorylation by
the MEK kinases, resulting in a substantial translocation of
phosphorylated ERK to the nucleus, where it functions to
modify the activity of transcription factors, thereby regulating
genetic program.(22) Using an antibody that specifically recognizes
the dually phosphorylated-activated form of ERK, we found that
under serum-starved conditions basal phosphorylation of ERK
Fig. 2. B-1 physically interacts with B16 in vitro. (a) B16 cells were
cultured for 72 h alone (B16), cocultured with B1 (B16 + B1), or placed
in conditioned medium from 5 days with cultures of either B-1 cells (B1-
med) or cocultures of B16/B1 cells (B16/B1-med). After this period, B16
cells from monocultures or B16/B-1 cells free from coculture were
collected and submitted to experimental metastasis assay. Bars
represent the mean number of tumor colonies per lung per
experimental condition ± SE. P < 0.05 represents statistical significance.
(b) Transmission electron microscopy of B16 and B-1 cells from
cocultures of 48 h. Arrows indicate points of interaction between B-1
and B16 cell membranes. (Scale bar: 1 μm).
Fig. 3. Extracellular signal–related kinase (ERK) phosphorylation is
increased in B16F10 after coculture with B-1. (a) B16 and (b) B-1
monocultures were serum starved overnight and stimulated or not
with 10% fetal calf serum (FCS) for 1 h, as indicated. (c) B16 cultured
alone or 1 × 106 B16 cells cocultured with different concentrations of B-
1 cells, as indicated, were cultured for 72 h. After this period, B16 cells
cultivated alone or B16/B-1 cells free from cocultures were analyzed for
detection of phospho-ERK levels. Whole-cell extracts of each treatment
were probed with antiphospho-ERK (p-ERK) and anti-ERK (Total ERK)
by Western blot analysis.
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was detected in both B16 and B-1 cells (Fig. 3a,b). On the other
hand, B16 showed a slight increase in the phosphorylation of
ERK upon addition of serum, whereas in B-1 phospho-ERK
levels remained unchanged, indicating that both cell types have
ERK phosphorylation constitutively.
To test whether interaction with B-1 would augment the lev-
els of phospho-ERK in B16, these cells were cocultured or not
for 72 h with different concentrations of B-1 cells. After this
period, cell extracts of B16 monocultures or B16/B-1 cells free
from cocultures were produced and submitted to immunobloting
for detection of ERK phosphorylation. As shown in Figure 3c, a
considerable increase in phosphorylation of ERK was observed
in B16 when up to 105 B-1 cells were present in the cocultures.
Interestingly, this result clearly correlates with the B-1 dose-
dependent increased metastatic behavior of B16 cells shown in
Figure 1c.
Increased metastatic potential of B16 cells is mediated by the up-
regulation of ERK phosphorylation. We asked whether increased
phosphorylation of ERK induced by B-1 contributes to the
enhanced metastatic potential of B16. Therefore, we first treated
B16 monocultures in the presence or absence of different
concentrations of either PD98059 or U0126, two pharma-
cological inhibitors of MEK, which is the upstream kinase of
ERK. As shown in Figure 4a,b, basal levels of ERK pho-
sphorylation were almost completely abrogated in B16
monocultures in the presence of 40 μM PD98059 or with 10 μM
U0126, respectively. Treatment with PD98059 or U0126 at
concentrations and time of incubation did not affect the cell
viability of B16 cells as determined by trypan blue staining
(data not shown).
Next we checked if using either PD98059 or U0126 to pre-
vent the increased phosphorylation of ERK induced by B-1
would inhibit the enhanced metastatic behavior of B16. There-
fore, cocultures of B16/B-1 cells were treated or not with differ-
ent concentrations of PD98059 or U0126 for 72 h. After this
period, B-1 cells were eliminated from the cocultures and B16
cells only were submitted either to immunobloting for detection
of phospho-ERK levels or to experimental metastasis assay. As
shown in Figure 4c,d (upper panel), irrespective of whether coc-
ultures were treated with 40 μM PD98059 or with 10 μM
U0126, but not bellow these concentrations, phospho-ERK
remained at levels similar to those observed in untreated B16
single cultures. In contrast, phospho-ERK levels were increased
in B16 from untreated cocultures. Interestingly, by preventing
the increased phosphorylation of ERK induced by B-1 with
either of the MEK inhibitors, the numbers of B16 metastatic
nodules were not as statistically different as those found in ani-
mals injected with B16 cultured alone in the absence of the
drugs, while B16 from untreated cocultures developed signifi-
cantly more metastatic nodules (Fig. 4c,d, compare upper and
lower panel). Together these results indicate that there is a clear
association between increased phosphorylation of ERK induced
by B-1 and the augmentation of the metastatic potential of B16
cells.
B-1 induces metastasis-related gene expression in B16 cells. To
further explore the biological influence of B-1 on the metas-
tatic potential of B16 cells, we evaluated the expression of
metastasis-related genes such as metalloproteinase-9 (MMP-9)
and the chemokine receptor CXCR4.(23–27) As shown in Figure 5,
MMP-9 and CXCR4 mRNA expression were enhanced in B16
cells which were cocultured with B-1 compared to B16 cells
cultured alone. In contrast, increased MMP-9 and CXCR4
mRNA expression were inhibited in B16 cells from cocultures
with B-1 in the presence of PD98059. Together these results
suggest that the increased phosphorylation of ERK induced by
B-1 regulates the expression of metastasis-related genes in B16
cells, which in turn may contribute to their enhanced metastatic
behavior.
B-1 requires constitutive levels of ERK phosphorylation to change
the metastatic potential of B16 cells. Our results showed that ex
vivo B-1 cells have constitutive levels of ERK phosphorylation
(Fig. 3b). Therefore, we evaluated if this signaling pathway is
implicated in the commitment of B-1 to mediate the increased
metastatic potential of B16.
It is known that B-1 cells produce and utilize IL-10 as an
autocrine growth factor.(28) Moreover, there have been several
reports suggesting that IL-10 promotes ERK activation,(29–32)
while others have associated the efficient transcription of IL-10
with ERK activity.(33) Based on these premises, we checked
the status of ERK phosphorylation in B-1 cells derived from the
Fig. 4. Increased metastatic behavior of
B16 cells induced by B-1 is dependent on
the levels of extracellular signal–regulated
kinase (ERK) phosphorylation. (a,b) B16 and
B-1 cells were cultured alone in complete
medium and treated or not with different
concentrations of PD098059 or U0126 for
24 h, as indicated. After this period,
extracts were prepared and analyzed for
detection of phospho-ERK levels by
Western blot. (c,d) B16 cells were cultured
alone or B16 + B1 cells were cocultured
in the absence (B16 + B1) or presence of
different concentrations of either
PD098059 or U0126 for 72 h, as indicated.
After this period, B16 cells from
monocultures or B16/B-1 cells free from
cocultures were collected and submitted
to either immunobloting analysis for
detection of phospho-ERK levels (upper
panel) or to experimental metastasis assay
(lower panel). Bars represent the mean
number of tumor colonies per lung per
experimental condition ± SE. P < 0.05
represents statistical signficance.
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peritoneal cavity of IL-10 knockout mice. As shown in
Figure 6a, IL-10 was present in the supernatant of B-1 cultures
from wild-type mice (B-1 wt), whereas it was absent in cultures
of B-1 from IL-10 knockout mice (B-1 KO). Interestingly, ERK
phosphorylation levels were notably lower in B-1 KO compared
to those found in B-1 wt (Fig. 6b), showing that the magnitude
of constitutive ERK phosphorylation is different in these two
cells. When we checked ERK phosphorylation in B16 from coc-
ultures with B-1 KO, phospho-ERK remained basal, whereas
these levels were augmented in B16 from cocultures with B-1
wt (Fig. 6c). In addition, increased phosphorylation of ERK
was impaired in B16 from cocultures in which B-1 wt were pre-
treated with 40 μM PD98059 before coculturing (Fig. 6c), a
concentration which was able to completely inhibit ERK phos-
phorylation in B-1 cells cultured alone (Fig. 6d). Consistent
with these findings, cocultures in the presence of B-1 wt, but not
with B-1 KO or B-1 wt pretreated with PD98059, increased the
metastatic behavior of B16 cells as revealed by the numbers of
lung colonies (Fig. 6e). Taken together, these results support the
hypothesis that constitutive levels of ERK phosphorylation in
B-1 take part in the commitment of these cells to affect the
metastatic potential of B16.
To rule out that IL-10 produced by B-1 wt could increase
ERK phosphorylation in B16, these cells were treated with
recombinant IL-10 (rIL-10). As shown in Figure 7, rIL-10 was
not able to increase phospho-ERK levels (Fig. 7a) and this was
correlated with the inability of either rIL-10 or conditioned
Fig. 6. B-1 requires constitutive levels
of phospho-extracellular signal–regulated
kinase (ERK) to increase the metastatic
behavior of B16 cells. (a) Determination of
interleukin-10 (IL-10) production in culture
supernatants of B-1 cells isolated either
from wild-type mice (B-1wt) or from IL-10
knockout mice (B-1KO). (b–d) Western blot
analysis for detection of phospho-ERK
levels; (b) total extracts from monocultures
of B-1wt and B1KO; (c) B16 cells were
serum-starved overnight and cocultured or
not for 48 h with B1wt (B16 + B1wt), B1KO
(B16 + B1KO), or with B-1wt pretreated
with 40 μM PD98059 for 24 h before
coculturing (B16 + [B1wt + PD]). Cells from
monocultures or B16/B-1 cells free from
cocultures were collected and total extracts
were produced. (d) B-1 cells monocultures
were treated or not with different
concentrations of PD98059 for 24 h. (e) B16
cells were treated as described in (c) and
B16 cells from monocultures or B16/B-1 cells
free from cocultures were collected and
submitted to experimental metastasis assay.
Bars represent the mean number of tumor
colonies per lung per experimental con-
dition ± SE. P < 0.05 represents statistical
significance.
Fig. 5. B-1 induces the expression of metastasis-related genes in B16.
B16 cells were either cultured alone or cocultured with B-1 in the
presence or absence or PD98059 (40 μM) for 48 h. For cocultures, only
B16/B-1 cells free after coculture were analyzed. The relative levels of
matrix metalloproteinase-9 (MMP-9) and CXCR4 were measured by
real-time polymerase chain reaction. Each value represents the mean ±
SEM for three samples. P < 0.05 represents statistical significance.
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medium from B-1 wt cultures to enhance the metastatic poten-
tial of B16 (Fig. 7b).
Discussion
Melanoma invasion and metastasis formation is a multifactorial
process and extensive research has demonstrated that regulatory
signals originate from the surrounding host cells either directly
through physical contact or indirectly through soluble factors,
and extracellular matrix molecules are critical determinants of
melanoma development.(34,35)
In the current study, we presented evidence that in vitro inter-
action of low-metastatic murine melanoma cells (B16) with B-1
cells, an exclusive subset of B lymphocyte that are found pre-
dominantly in pleural and peritoneal cavities,(15,16) resulted in
metastatic potential enhancement of B16. Our results showed
that B16/B-1 cells physically interact in vitro and that B-1 solu-
ble factors are not sufficient to induce the increased metastatic
behavior of B16, suggesting that cell–cell contact participates in
this effect.
We also suggest that the metastasis-promoting effects of B-1
on B16 cells requires activation of the ERK signaling pathway.
B16 cells from cocultures with B-1 presented increased ERK
phosphorylation. When the augmentation of ERK phosphoryla-
tion was prevented by different MEK inhibitors, the increased
metastatic behavior of B16 cells was impaired. In contrast, B16
cells cultured alone showed constitutive basal levels of ERK
phosphorylation, and complete inhibition of ERK activity in
these cells with either of the MEK inhibitors did not inhibit their
ability to form metastases (Fig. 4c,d, and data not shown). This
observation suggests that the intrinsic phenotype of this low-
metastatic melanoma cell line may be supported by another
pathway unrelated to the minimal background of ERK activity.
Interestingly, phospho-ERK levels in B16 cells from cocultures
with B-1 were increased above the basal levels observed in B16
cultured alone, showing that mediated B-1 increased phosphor-
ylation of ERK over this threshold is required to trigger more
aggressive metastatic behavior.
There is substantial evidence that suggests that activation of
the ERK pathway is important to melanoma cell invasion, motil-
ity, and MMP production,(36–38) and therefore the activation may
be necessary for extravasation and/or for migration to a support-
ive environment in the lung. Indeed, we have found increased
mRNA expression of MMP-9 in B16 cells cocultured with B-1,
whereas treatment of cocultured cells with the MEK inhibitor
(PD98059) counteracted this effect. Like others, our data sup-
port the role of the ERK signaling pathway as being involved
in the regulation of MMP-9 expression in cancer cells.(23,39,40)
Moreover, mRNA expression of the chemokine receptor
CXCR4, which has been described as playing an important role
in metastasis, providing migratory direction to tumor cells,(41)
was also increased in B16 cells cocultured with B-1. The role of
CXCR4 in melanoma metastasis is consistent with previously
reported findings showing that B16 melanoma cells transfected
with CXCR4 produced an increased number of pulmonary nod-
ules compared to mock-transfected cells.(42) Strikingly, we
showed that mRNA expression of CXCR4 was abolished in B16
from cocultures with B-1 in the presence of PD98059, suggest-
ing that CXCR4 expression is by some means controlled by the
increased activity of ERK induced by B-1. Although the mech-
anism for this effect remains to be defined, a recent report has
provided evidence that downstream components of the ERK
pathway, such as Ets1, play a critical role in CXCR4 transcrip-
tion and protein expression.(43)
A remarkable finding in this report was the requirement of
constitutive levels of ERK phosphorylation in B-1 for their com-
mitment to induce the increased metastatic potential of B16. We
showed that when inhibiting constitutive phosphorylation of
ERK in B-1 cells with PD98059, neither ERK phosphophoryla-
tion nor the metastatic potential of B16 cells were increased.
This observation was further supported by studies using B-1
cells from IL-10 knockout mice which showed considerably low
levels of constitutive ERK phosphorylation compared to higher
levels in B-1 cells from wild-type mice. Moreover, transmission
electron microscopy from cocultures of B16/B1 cells, where B-
1 cells were either pretreated with PD98059 before coculturing
or both cell types were cocultured in the presence of PD98059,
reveled the absence of physical-membrane contact between
these cells (data not shown), suggesting that constitutive
ERK activity in B-1 plays a role in mediating this heterotypic
interaction.
Constitutive phosphorylation of ERK has been previously
demonstrated in B-1 but not in B-2 cells.(44) Although ERK
activity is not necessary for the extended survival of B-1 cells in
culture,(44) it is currently unknown what functional aspects of B-
1 cell physiology are regulated by this kinase. Considering our
results, we do not yet comprehend why B-1 cells require consti-
tutive levels of ERK phosphorylation to increase the metastatic
potential of B16 cells. However, accumulating evidence has
demonstrated that differences in the duration, magnitude, and
subcellular compartmentalization of ERK activity determine
signaling specificity.(45–47) Since our data argue in favor of a
physical contact between B-1 and B16 cells, it is reasonable
to speculate that only at the extent of constitutive levels, but
not below this threshold, can phosphorylated ERK control reg-
ulatory programs by allowing the expression of B-1-specific
Fig. 7. Phospho-extracellular signal–regulated kinase (ERK) levels and
the metastatic behavior of B16 cells are not increased by recombinant
interleukin-10 (rIL-10). (a) B16 cells were serum starved overnight and
cells were treated or not with different concentrations of recombinant
IL-10 (rIL-10) for different times or stimulated with 10% fetal calf
serum (FCS) for 1 h, as indicated. Total cell extracts were produced and
analyzed for phospho-ERK levels by Western blot. (b) B16 cells were
serum starved overnight and cocultured or not with B-1 cells for 48 h
in the presence or absence of different concentrations of rIL-10 or B-1
conditioned medium (B1-med), as indicated. B16 cells from
monocultures or B16/B-1 cells free from cocultures were collected and
submitted to experimental metastasis assay. Bars represent the mean
number of tumor colonies per lung per experimental condition ± SE.
P < 0.05 represents statistical significance.
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cell-surface molecule(s), which in turn communicates with B16
cells through an interactive network of cell–cell signaling.
In addition to constitutive ERK activation, it has been sug-
gested that B-1 cells also present constitutively active forms of
the signal transducer and activator of transcription (Stat)-3,
which seems to play a role in the self-renewing growth charac-
teristics of B-1 cells.(48–50) Although the role of tyrosine phos-
phorylation for Stat3 nuclear translocation and transactivation of
responsive genes(51) is clear, evidence suggests that phosphoryla-
tion at a serine residue (Ser727) on Stat3 also regulates its tran-
scriptional activity.(52,53) However, there is conflicting evidence
about the identity of the kinase responsible for this serine phos-
phorylation and also its functions, with some reports attributing
the phosphorylation to the ERKs.(54) Whether the requirement
of constitutive ERK activity in B-1 to increase the metastatic
potential of B16 is mediated by phosphorylation of Stat3 on
Ser727 remains to be determined.
To our knowledge, these data provide the first evidence that
B-1-lymphocytes can directly impact on the metastatic potential
of tumor cells. Although in vivo B-1 cells home predominantly
in on the peritoneal and pleural cavities, these cells can exit
from coelomatic cavities and migrate to an inflammatory milieu
where they differentiate into macrophage-like cells, implying
that myeloid and lymphoid lineages may have a common ances-
try.(17) Infiltration of myeloid lineage cells into malignant tissue
is a common feature of many epithelial neoplasms and is thought
to contribute to cancer development. In this scenario, it is possible
to envisage that B-1 cells can also migrate to neoplastic lesions
in vivo, contributing to metastatic spread. We are currently
addressing this question by examining tumor tissue isolates for
the presence of B-1 cells. It will be of great interest to determine
whether the observed effect of B-1 on the metastatic behavior
of melanoma cells presented in this study also takes place in
such dynamic microenvironmental contexts in vivo.
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